"Our priorities will include identifying and understanding the challenges while engaging regularly with industry leaders to address their concerns"

K Raja Bhanu has been elevated from Executive Director to Director General of the Pharmaceuticals Export Promotion Council of India (Pharmexcil), effective July 1, 2024. Bhanu brings a wealth of experience from his distinguished career in drug control and regulation. He has a proven track record in advancing drug quality, safety, and regulatory compliance. His leadership at the Drug Control Administration (DCA) was marked by significant initiatives that enhanced drug regulation standards and reinforced India's pharmaceutical reputation globally. In his current role, Bhanu is set to drive the expansion of India's pharmaceutical exports, boost global competitiveness, and adeptly navigate the complexities of international regulations, leveraging his extensive expertise to foster industry growth and global prominence. In an interaction with BioSpectrum, he shared his plans on addressing many challenges before the Indian pharma industry to stay compliant with international regulations. Edited excerpts:

- Amguth Raju

How do you feel after being appointed as Director General at Pharmexcil and what are your priorities?

I am truly honoured to assume the role of Director General of Pharmexcil. I am grateful to all the industry stakeholders and the government for their trust in my leadership. This position is a significant responsibility, and I am committed to addressing the key challenges facing the pharmaceutical export sector. Building on the successful initiatives of my predecessors, my priorities will include identifying and understanding these challenges, engaging regularly with industry leaders to address their concerns, and representing their interests to both state and central governments, as well as international agencies, to achieve effective solutions.

Could you provide an overview of the current export scenario of Indian pharmaceuticals in the global markets?